Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist

British Journal of Pharmacology

Volumn 122, Issue 5, 1997, Pages 809-812

  Taniguchi, Kana ^a   Shinjo, Katsuhiro ^a   Mizutani, Mayumi ^a   Shimada, Kaoru ^a   Ishikawa, Toshihisa ^a   Menniti, Frank S ^a   Nagahisa, Atsushi ^a  

^a PFIZER INC   (United States)

Author keywords

CP 101,606; Hyperalgesia; NMDA receptor antagonist; Nociception

Indexed keywords

CAPSAICIN; CARRAGEENAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; TRAXOPRODIL; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HYPERALGESIA; MALE; MOTOR COORDINATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, NON-NARCOTIC; ANIMALS; BRAIN; CAPSAICIN; CARRAGEENAN; EXCITATORY AMINO ACID ANTAGONISTS; HYPERALGESIA; INJECTIONS, SUBCUTANEOUS; MALE; MOTOR ACTIVITY; PAIN MEASUREMENT; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; TETRADECANOYLPHORBOL ACETATE;

EID: 0030771671     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701445     Document Type: Article

References (11)

1. CARTER, C.J., LLOYD, K.G., ZIVKOVIC, B. & SCATTON, B. (1990). Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J. Pharmacol. Exp. Ther., 253, 475-482.
2. CHENARD, B.L., BORDNER, J., BUTLER, T.W., CHAMBERS, L.K., COLLINS, M.A., DECOSTA, D.L., DUCAT, M.F., DUMONT, M.L., FOX, C.B., MENA, E.E., MENNITI, P.S., NIELSEN, J., PAGNOZZI, M.J., RICHTER, K.E.G., RONAU, R.T., SHALABY, I.A., STEMPLE, J.Z. & WHITE, W.F. (1995). (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J. Med. Chem., 38, 3138-3145.
3. DICKENSON, A.H. (1990). A cure for wind up: NMDA antagonists as potential analgesics. Trends Pharmacol. Sci., 11, 307-309.
4. ISHII, T., MORIYOSHI, K., SUGIHARA, H., SAKURADA, K., KADOTANI, H., YOKOI, M., AKAZAWA, C, SHIGEMOTO, R., MIZUNO, N., MASU, M. & NAKANISHI, S. (1993). Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem., 268, 2836-2843.
5. MENNITI, F., CHENARD, B., COLLINS, M., DUCAT, M., SHALABY, I. & WHITE, F. (1997). CP-101,606, a potent neuroprotectant selective for forebrain neurons. Eur. J. Pharmacol. (in press).
6. PAGNOZZI, M.J., CHAMBERS, L.K., MENNITI, F.S., CHENARD, B.L. & WHITE, W.F. (1995). CP-101,606, a potent and selective antagonist of forebrain NMDA receptors: in vivo activity. Soc. Neurosci. Abstr., 21, 1114.
7. RANDALL, L.O. & SELITTO, J.J. (1957). A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn., 111, 409-419.
8. SAKURADA, T., KATSUMATA, K., TAN-NO, K., SAKURADA, S. & KISARA, K. (1992). The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology, 31, 1279-1285.
9. WHITE, W.F., DUCAT, M.F., CHENARD, B.L., BUTLER, T.W. & RONAU, R.T. (1995). CP101,606, a potent and selective antagonist of forebrain NMDA receptors: binding to a novel recognition site. Soc. Neurosci. Abstr., 21, 1114.
10. WILLIAMS, K., RUSSELL, S.L., SHEN, V.M. & MOLINOFF, P.B. (1993). Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron, 10, 267-278.
11. WILLIAMS, K. (1995). Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the ε4 (NR2D) subunit. Neurosci. Lett., 184, 181-184.